March Emerging Medical Technologies Report

Published January 2014 | 27 Pages | 30 Exhibits |

Order individually or subscribe to Medtech Pro and get a complete intel platform.


This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in March 2014. Additionally, read LSI's "Innovator of the Month" Interview with:

- Daniel Burnett, MD, President & CEO, TheraNova, LLC

All companies include technology, market(s), key executive, and contact information.

Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companies
- Drug Delivery Companies
- Endocrine Companies
- Gastroenterology Companies
- Gynecology/Women's Health Companies
- Imaging Companies
- Neurology Companies
- Oncology Companies
- Ophthalmology Companies
- Orthopedics Companies
- Pain Management Companies
- Patient Management/Monitoring Companies
- Pharmaceutical Companies
- Respiratory Companies
- Spine Companies
- Surgery Companies
- Urology Companies
- Vascular Companies
- Wound Management Companies

This report may be purchased separately or is automatically provided to subscribers of LSI's Emerging Medical Technologies® Database.


Table of Contents


  • A soft, flexible, bandage-like patch pump for active and simultaneous subcutaneous delivery of one or more medications, including insulin
  • A technology which involves a series of self-assembling magnets for incision-less bypass procedures within the digestive system
  • Advanced visualization technology for surgery
  • An FDA Class I, external neuro-stimulation medical device clinically shown to immediately reduce the blood pressure of hypertensive patients, via controlled cold therapy
  • An innovative infusion pump which will provide totally accurate delivery of prescribed drugs to people suffering from chronic illnesses such as diabetes and neurodegenerative diseases
  • Antimicrobial orthopedic implants for the prevention and treatment of bone-based infections
  • Biomaterials that stimulate the regeneration of bone by a novel mechanism known as osteoinductive nanoarchitecture
  • Corneal lens implant for the treatment of presbyopia, the age-related loss of the ability to read or focus on near objects
  • Diagnosis devices that measure ocular motility
  • Endoscopic vein harvesting technology
  • Hand-held device and secured web service-based platform enabling anyone anywhere to perform an accurate physical examination for remote diagnosis
  • Image-guided non-invasive brain stimulation
  • Injectable silk hydrogel for the treatment of osteoarthritis
  • Medical device technologies to improve outcomes in transcatheter aortic valve replacement procedures
  • Miniaturized implantable neuromodulation technology; lead products are directed toward a number of clinical indications including the treatment of chronic pain and overactive bladder
  • Molecular diagnostic device for the rapid detection of sepsis or other infection, to reduce unnecessary antibiotic use, and boost patient outcomes and healthcare facility efficiency
  • Molecular diagnostics test focused on detecting sepsis in critical care patients
  • Noninvasive solutions for people with sleep disordered breathing, that work by creating expiratory positive airway pressure
  • Noninvasive treatment for acute and chronic kidney disease using low frequency therapeutic ultrasound
  • One-step, point-of-care diagnostic that uses proprietary chemistry to measure enzymes to help clinicians determine how to treat chronic (or non-healing) wounds
  • Ophthalmic drug delivery technology
  • Ophthalmic surgical devices and instrumentation
  • Optical imaging technology used during cancer surgery
  • Point-of-care device that can rapidly detect and diagnose trauma-induced coagulopathy
  • Simple fluid flow control module that can be incorporated within finished medical products, such as intravenous infusion pumps, enteral feeding devices, and patient monitoring systems
  • State-of-the-art products for corneal cross-linking of corneal collagen fibers by combined riboflavin/UVA illumination for the treatment of progressive keratoconus
  • Synthetic bone substitute
  • Technologies that minimize peak skin interface pressures to prevent and expedite treatment of pressure ulcers/sores
  • Temporary cardiac pacing device to treat reversible symptomatic bradycardia
  • Wound treatment system which facilitates timely cleaning of trauma wounds such as road rash

Companies We Work With